Clostridioides difficile Infection: Use of Inflammatory Biomarkers and Hemogram-Derived Ratios to Predict Mortality Risk in Hospitalized Patients.

Publication date: Aug 15, 2024

Clostridioides difficile infection (CDI) is a significant cause of mortality, especially in healthcare environments. Reliable biomarkers that can accurately predict mortality in CDI patients are yet to be evaluated. Our study aims to evaluate the accuracy of several inflammatory biomarkers and hemogram-derived ratios in predicting mortality in CDI patients, such as the neutrophil-to-lymphocyte ratio (NLR), the systemic immune-inflammation index (SII), the platelet-to-neutrophil ratio (PNR), the derived neutrophil-to-lymphocyte ratio (dNLR), C-reactive protein (CRP), the platelet-to-lymphocyte ratio (PLR), and procalcitonin (PCT). NLR showed a sensitivity of 72. 5% and a specificity of 58. 42% with an area under curve (AUC) = 0. 652. SII had a sensitivity of 77. 5%, a specificity of 54. 74%, and an AUC = 0. 64. PNR, neutrophils, dNLR, and lymphocytes had lower AUCs which ranged from 0. 595 to 0. 616, with varied sensitivity and specificity. CRP, leukocytes, and platelets showed modest predictive values with AUCs below 0. 6. PCT had a sensitivity of 100%, a low specificity of 7. 41%, and an AUC = 0. 528. We conducted a retrospective analysis of CDI patients from two different hospital settings in Italy and Romania during the COVID-19 pandemic, from 1 January 2020 to 5 May 2023. Statistical analyses included t-tests, Wilcoxon rank-sum tests, χ2 tests, and multivariate logistic regression to identify predictors of mortality. ROC analysis assessed the accuracy of biomarkers and hemogram-derived ratios. A p value < 0. 05 was considered significant. Neutrophils, dNLR, NLR, SII, and PNR are valuable biomarkers for predicting mortality in CDI patients. Understanding these predictors can improve risk stratification and clinical outcomes for CDI patients.

Open Access PDF

Concepts Keywords
Basel antimicrobial stewardship
Healthcare Clostridioides difficile
Pandemic COVID-19
Platelets infection control
personalized medicine
predictors

Original Article

(Visited 1 times, 1 visits today)